Cargando…

Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab

Although vascular endothelial growth factor (VEGF) promotes the immunosuppressive microenvironment, the efficacy of bevacizumab (Bev) on tumor immunity has not been fully investigated. The present study used 47 glioblastoma tissues obtained at 3 different settings: tumors of initial resection (naïve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamura, Ryota, Tanaka, Toshihide, Ohara, Kentaro, Miyake, Keisuke, Morimoto, Yukina, Yamamoto, Yohei, Kanai, Ryuichi, Akasaki, Yasuharu, Murayama, Yuichi, Tamiya, Takashi, Yoshida, Kazunari, Sasaki, Hikaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361613/ https://www.ncbi.nlm.nih.gov/pubmed/30467920 http://dx.doi.org/10.1111/cas.13889

Ejemplares similares

“Paradoxical” findings of tumor vascularity and oxygenation in recurrent glioblastomas refractory to bevacizumab
por: Yamamoto, Yohei, et al.
Publicado: (2017)

ANGI-01 ALTERATION IN IMMUNE REGULATORY CELLS BEFORE AND AFTER TREATMENT BY STUPP REGIMEN WITH OR WITHOUT BEVACIZUMAB FOR GLIOBLASTOMA
por: Tanaka, Toshihide, et al.
Publicado: (2019)

Histopathological investigation of glioblastomas resected under bevacizumab treatment
por: Tamura, Ryota, et al.
Publicado: (2016)

Alterations of the tumor microenvironment in glioblastoma following radiation and temozolomide with or without bevacizumab
por: Tamura, Ryota, et al.
Publicado: (2020)

Immunosupportive therapies in aging
por: Fülöp, Tamas, et al.
Publicado: (2007)

Impact of Neoadjuvant Bevacizumab on Neuroradiographic Response and Histological Findings Related to Tumor Stemness and the Hypoxic Tumor Microenvironment in Glioblastoma: Paired Comparison Between Newly Diagnosed and Recurrent Glioblastomas
por: Takei, Jun, et al.
Publicado: (2022)

ANGI-1 Impact of neoadjuvant bevacizumab on transcriptional factor for stemness, macrophage polarization, and oxygenation of tumor microenvironment in glioblastoma
por: Tanaka, Toshihide, et al.
Publicado: (2021)

ANGI-1 ASSESSING THE THERAPEUTIC EFFECT OF BEVACIZUMAB USING FMISO-PET IN GBM THERAPY
por: Suzuki, Tomoya, et al.
Publicado: (2022)

A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma
por: Tamura, Ryota, et al.
Publicado: (2020)

COT-08 Analysis of prognosis of biopsy/partial resection cases of malignant glioma
por: Yamamoto, Yohei, et al.
Publicado: (2020)

IMT-02 VEGF RECEPTORS EXPRESSION AND REPORT OF CLINICAL TRIAL OF PEPTIDE VACCINE IN SKULL BASE CHORDOMA
por: Morimoto, Yukina, et al.
Publicado: (2019)

IMT-1 A translational research for practical use of dendritic cell-based immunotherapy against malignant glioma
por: Akasaki, Yasuharu, et al.
Publicado: (2021)

MET-4 ANALYSIS OF METASTATIC BRAIN TUMORS DISCOVERED AT THE SAME TIME AS THE PRIMARY LESION
por: Yamamoto, Yohei, et al.
Publicado: (2022)

IMT-01 THERAPEUTIC EFFECT AGAINST LOWER GRADE GLIOMA INDUCED BY DENDRITIC CELL BASED IMMUNOTHERAPY
por: Akasaki, Yasuharu, et al.
Publicado: (2019)

A case of acute subdural hematoma due to bleeding from metastatic chondrosarcoma of the skull
por: Kosugi, Kenzo, et al.
Publicado: (2017)

CS-01 Rapid Recurrence and Anaplastic Transformation of a Pilocytic Astrocytoma in an Elderly Patient
por: Tanaka, Toshihide, et al.
Publicado: (2020)

IMT-1 PROS AND CONS OF SURGICAL INTERVENTION FOR DIFFUSE MIDLINE GLIOMA AIMED AT DENDRITIC CELL IMMUNOTHERAPY
por: Akasaki, Yasuharu, et al.
Publicado: (2022)

BIMG-06. RESPONSE ASSESSMENT OF BEVACIZUMAB THERAPY FOR GLIOBLASTOMA BY USING MULTIPLE PET TRACERS
por: Miyake, Keisuke, et al.
Publicado: (2021)

GCT-51. IMMUNE CHECKPOINT MOLECULES AND TUMOR INFILTRATING LEUKOCYTES IN THE TUMOR MICROENVIRONMENT ARE ASSOCIATED WITH THE GROWTH OF INTRACRANIAL GERMINOMAS
por: Nishimoto, Masaaki, et al.
Publicado: (2020)

Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors
por: Sato, Mizuto, et al.
Publicado: (2019)

Long-Term Clinical Outcome of First Recurrence Skull Base Meningiomas
por: Kuranari, Yuki, et al.
Publicado: (2019)

Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients With Meningiomas
por: Kuranari, Yuki, et al.
Publicado: (2020)

A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma
por: Kikuchi, Ryogo, et al.
Publicado: (2019)

Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series
por: Tamura, Ryota, et al.
Publicado: (2020)

SPDR-2 Histopathological investigation of the oligodendroglial tumors resected following alkylating agent chemotherapy
por: Masato, Nakaya, et al.
Publicado: (2021)

Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series
por: Tamura, Ryota, et al.
Publicado: (2020)

Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma
por: Takei, Jun, et al.
Publicado: (2023)

Severe headache in a patient with meningioma showing extensive dural tail correlates with IgG4-positive plasma cells and eosinophils: A case report and review of literature
por: Kuranari, Yuki, et al.
Publicado: (2018)

Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
por: Tamura, Ryota, et al.
Publicado: (2020)

A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
por: Tamura, Ryota, et al.
Publicado: (2019)

Does afatinib plus bevacizumab combination therapy induce positive conversion of T790M in previously-negative patients?
por: Hata, Akito, et al.
Publicado: (2018)

Acute Heart Failure in a Patient with Occult Barlow’s Disease Receiving Bevacizumab
por: Izumida, Toshihide, et al.
Publicado: (2021)

PEDT-03 A clinical trial of dendritic cell-based immunotherapy for refractory brain tumors in children
por: Akasaki, Yasuharu, et al.
Publicado: (2020)

Visualization of spatiotemporal dynamics of human glioma stem cell invasion
por: Tamura, Ryota, et al.
Publicado: (2019)

Lipoma in the Corpus Callosum Presenting with Epileptic Seizures Associated with Expanding Perifocal Edema: A Case Report and Literature Review
por: Fuga, Michiyasu, et al.
Publicado: (2015)

Glioblastoma Treatment in the Elderly
por: OKADA, Masaki, et al.
Publicado: (2017)

Case Series of Endovascular Therapy for Blood Blister-Like Aneurysm in Acute Phase
por: Fujimori, Takeshi, et al.
Publicado: (2022)

Glycolytic fast-twitch muscle fiber restoration counters adverse age-related changes in body composition and metabolism
por: Akasaki, Yuichi, et al.
Publicado: (2014)

Chronic Encapsulated Expanding Thalamic Hematoma Associated with Obstructive Hydrocephalus following Radiosurgery for a Cerebral Arteriovenous Malformation: A Case Report and Literature Review
por: Takei, Jun, et al.
Publicado: (2016)

Gene therapy using genome‐edited iPS cells for targeting malignant glioma
por: Tamura, Ryota, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lp68l4lkhp2gkqrkk5ajpj3b27